Form 8-K - Current report:
SEC Accession No. 0001493152-24-015271
Filing Date
2024-04-19
Accepted
2024-04-19 08:31:40
Documents
15
Period of Report
2024-04-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42561
2 ex99-1.htm EX-99.1 19371
3 ex99-1_001.jpg GRAPHIC 2878
  Complete submission text file 0001493152-24-015271.txt   238046

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cqenscom-20240418.xsd EX-101.SCH 3018
5 XBRL LABEL FILE cqenscom-20240418_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cqenscom-20240418_pre.xml EX-101.PRE 22357
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3182
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55470 | Film No.: 24855691
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)